What is the Criteria to Get Ozempic for Weight Loss?

Last reviewed: June 23, 2026

Last updated: June 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, the active ingredient in Ozempic, has demonstrated a 15% average weight reduction in clinical trials when combined with lifestyle changes. However, not everyone qualifies for this medication, and access depends on meeting established medical criteria. PlexusDx helps eligible patients obtain compounded semaglutide through licensed pharmacies without requiring insurance or membership fees.

Body Mass Index Requirements for Semaglutide Eligibility

Medical guidelines establish BMI thresholds as the primary eligibility marker for semaglutide weight loss therapy. Patients with a BMI of 30 or higher generally qualify for treatment, or those with a BMI of 27 or higher who also have weight-related health conditions such as hypertension, type 2 diabetes, or sleep apnea. These cutoff points reflect decades of cardiovascular and metabolic research showing where weight reduction produces measurable health improvements.

Your starting BMI determines whether semaglutide fits within evidence-based treatment protocols. A healthcare provider calculates BMI by dividing weight in kilograms by height in meters squared, and this single number becomes the gateway to accessing therapy. PlexusDx evaluates BMI during the patient intake process to confirm medical appropriateness before dispensing compounded semaglutide injections.

Weight-Related Health Conditions That Support Eligibility

Having at least one obesity-related medical condition significantly strengthens your case for semaglutide therapy. Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, non-alcoholic fatty liver disease, and cardiovascular disease all represent conditions where weight reduction produces documented clinical benefits. Studies show that losing 5-10% of body weight improves blood sugar control, reduces medication burden, and lowers cardiovascular risk in patients carrying these diagnoses.

PlexusDx providers review your medical history to identify qualifying conditions during the consultation process. If you have been treated for diabetes, take blood pressure medication, have received a sleep apnea diagnosis, or struggle with cholesterol management, these conditions may position you as an ideal candidate for semaglutide therapy. The presence of comorbidities transforms semaglutide from a cosmetic option into a medically necessary intervention.

Age, Kidney Function, and Medical Screening Criteria

Semaglutide eligibility extends beyond BMI and includes age and organ function assessments. Adults aged 18 and older generally qualify, though healthcare providers evaluate kidney function through creatinine and estimated glomerular filtration rate measurements. Patients with severe kidney disease may face restrictions, as GLP-1 medications influence fluid balance and require careful monitoring in compromised renal systems. Thyroid history also matters; patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not use GLP-1 agonists.

Pregnancy status and breastfeeding plans represent additional screening factors because semaglutide crosses placental barriers and passes into breast milk. Women of childbearing age must confirm they are not pregnant and have contraception plans before starting therapy. PlexusDx healthcare providers conduct thorough medication reconciliation and medical history review to identify any contraindications before compounding and dispensing semaglutide injections.

How PlexusDx Confirms Your Eligibility for Compounded Semaglutide

PlexusDx streamlines the eligibility verification process by requiring basic health information, current medications, and medical history during the initial consultation. A licensed healthcare provider reviews your BMI calculation, existing diagnoses, kidney function status, and medication interactions to determine candidacy. This assessment ensures compounded semaglutide from licensed 503A pharmacies aligns with clinical guidelines and your personal health profile, with no insurance requirement or membership fees blocking access.

Once confirmed eligible, PlexusDx offers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan across all 50 states—pricing that remains flat regardless of dose adjustments. Your dose may need to go up as your body adapts and weight loss plateaus, but your price won't change. For patients seeking additional personalization, the Precision Peptide Genetic Test ($298) maps 14 metabolic pathways and 49 peptides, revealing genetic predispositions to GLP-1 response and helping optimize therapy selection between semaglutide, tirzepatide, or dual-compound protocols.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

What BMI do I need to qualify for semaglutide weight loss treatment?

You generally qualify with a BMI of 30 or higher, or a BMI of 27 or higher if you have weight-related conditions like diabetes, hypertension, or sleep apnea. PlexusDx verifies your BMI during consultation and confirms medical eligibility before dispensing compounded semaglutide injections.

Can I get semaglutide if I don't have diabetes or other health conditions?

Yes, a BMI of 30 or above alone qualifies you for semaglutide therapy under evidence-based guidelines. However, having weight-related comorbidities strengthens your case and demonstrates that therapy serves medical rather than purely cosmetic purposes, which aligns with standard prescribing protocols.

Does PlexusDx require insurance or membership to access semaglutide?

No. PlexusDx compounded semaglutide injections are available without insurance, membership fees, or prior authorization requirements. Pricing is $189 per month month-to-month, or from $149/mo on the 6-month plan and is HSA/FSA eligible, making treatment accessible across all 50 states.

Are there any conditions that disqualify me from semaglutide use?

Severe kidney disease, personal or family history of medullary thyroid carcinoma, pregnancy, and breastfeeding represent contraindications. PlexusDx providers screen for these conditions during consultation to ensure compounded semaglutide aligns with safety guidelines before treatment begins.

How does the Precision Peptide Genetic Test help determine if semaglutide is right for me?

PlexusDx's Precision Peptide Genetic Test ($298) analyzes 14 metabolic pathways and genetic variants including GIPR rs1800437, revealing your genetic predisposition to GLP-1 therapy response and helping providers personalize treatment selection between semaglutide, tirzepatide, or combination protocols.

Related Reading

• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic
• Ozempic Weight Loss Before And After Pictures

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.